Effects of biological clock gene Bmal1 on the expression of cell cycle-associated genes in chondrocytes

doi:10.16352/j.issn.1001-6325.2024.04.0496

Abstract

Abstract: Objective To explore the intrinsic relationship between circadian clock and cell cycle in osteoarthritis(OA) chondrocytes, especially the regulation of cell cycle-related genes by the clock gene Bmal1. Methods The chondroid ATDC5 cells induced by insulin-transfering-selenium(ITS) were divided into control group, OA group and LV-Bmal1 group. The cell viability of each group was detected by CCK8 method. The expression of Bmal1, Per1, Wee1, Cdk1, Ccnb1 and Mmp13 mRNA in each group was detected by RT-qPCR. The expression of BMAL1, PER1, WEE1, CDK1, CCNB1 and MMP13 protein in each group was detected by Western blot. The effects of Bmal1 on different stages of cell cycle and apoptosis was analyzed by flow cytometry. The regulation of Bmal1 on Per1, Wee1, Cdk1, Ccnb1 and Mmp13 and their roles in OA were analyzed. Results Compared with the normal group, the cell viability of the OA group was increased, the relative mRNA expression of Bmal1 and Wee1 in the OA group decreased, and the relative mRNA expression of Per1, Cdk1, Ccnb1 and Mmp13 increased significantly. The cell viability of LV-Bmal1 group decreased, the relative expression of Bmal1 and Wee1 mRNA increased, and the relative expression of Per1, Cdk1, Ccnb1 and Mmp13 mRNA decreased(P＜0.05). Correlation analysis showed that Bmal1 was positively correlated with Wee1 and they were negatively correlated with Per1, Cdk1, Ccnb1 or Mmp13. The results of Western blot showed that protein expression in different groups were consistent with the trend of PCR. The results of cell cycle and apoptosis showed that compared with the normal group, the S phase and G2/M phase of the OA group were shortened, the proportion of cells decreased significantly, and the proportion of early and late apoptosis increased. The S phase and G2/M phase of the LV-Bmal1 group were prolonged, the proportion of cells was increased, and the proportion of early and late apoptosis was decreased. Conclusions Circadian clock gene Bmal1 in inflammatory chondrocytes might regulate the expression of cell cycle-related genes.

Key words: biological clock, cell cycle, osteoarthritis, chondrocytes, apoptosis

CLC Number:

YANG Chunsheng, WANG Tianxing, ZHANG Tiecheng, WU Hengmin, WANG Baolan. Effects of biological clock gene Bmal1 on the expression of cell cycle-associated genes in chondrocytes[J]. Basic & Clinical Medicine, 2024, 44(4): 496-502.

References 14

[1]	Cui A, Li H, Wang D, et al. Global, regional preval-ence, incidence and risk factors of knee osteoarthritis in population-based studies[J]. EClinicalMedicine, 2020,26:29-30:100587. doi:10.1016/j.eclinm.2020.100587.
[2]	GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990—2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet Rheumatol, 2023, 5: e508-e522.
[3]	Fang CL, Liu B, Wan M. “Bone-SASP” in skeletal aging[J]. Calcif Tissue Int, 2023, 113: 68-82.
[4]	Gao Y, Wang S, He L, et al. Alpinetin protects chondrocytes and exhibits anti-inflammatory effects via the NF-κB/ERK pathway for alleviating osteoarthritis[J]. Inflammation, 2020, 43: 1742-1750.
[5]	Zhao C, Sun G, Li Y, et al. Forkhead box O3 attenuates osteoarthritis by suppressing ferroptosis through inactiva-tion of NF-κB/MAPK signaling[J]. J Orthop Translat,2023, 39: 147-162.
[6]	Chen G, Tang Q, Yu S, et al. The biological function of BMAL1 in skeleton development and disorders[J]. Life Sci, 2020,253: 117636. doi: 10.1016/j.lfs.2020.117636.
[7]	Qu M, Zhang G, Qu H, et al. Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle[J]. Proc Natl Acad Sci U S A,2023, 120: e2214829120. doi: 10.1073/pnas.2214829120.
[8]	Barajas JM, Lin CH, Sun HL, et al. METTL3 regulates liver homeostasis, hepatocyte ploidy, and circadian rhythm-controlled gene expression in mice[J]. Am J Pathol, 2022, 192: 56-71.
[9]	Jokoji G, Maeda S, Oishi K, et al. CDC5L promotes early chondrocyte differentiation and proliferation by modulating pre-mRNA splicing of SOX9, COL2A1, and WEE1[J]. J Biol Chem, 2021,297: 100994. doi: 10.1016/j.jbc.2021.100994.
[10]	Martin JC, Sims JR, Gupta A, et al. WEE1 inhibition augments CDC7(DDK) inhibitor-induced cell death in Ewing sarcoma by forcing premature mitotic entry and mitotic catastrophe[J]. Cancer Res Commun, 2022, 2: 471-482.
[11]	Jennings L, Walters HA, Mason JM. FBH1 deficiency sensitizes cells to WEE1 inhibition by promoting mitotic catastrophe[J]. bioRxiv,2023: 2023.05.15.540841. doi: 10.1016/j.dnarep.2023.103611.
[12]	Chang LC, Yu YL, Liu CY, et al. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1[J]. Cancer Chemother Pharmacol, 2015, 75: 1303-1315.
[13]	Nie BX, Zhao G, Yuan XF, et al. Inhibition of CDK1 attenuates neuronal apoptosis and autophagy and confers neuroprotection after chronic spinal cord injury in vivo[J]. J Chem Neuroanat, 2022, 119: 102053. doi: 10.1016/j.jchemneu.2021.102053.
[14]	Vitovcov B, Skarkova V, Rudolf K, et al. Biology of glioblastoma multiforme-exploration of mitotic catastrophe as a potential treatment todality[J]. Int J Mol Sci,2020, 21: 5324. doi: 10.3390/ijms21155324.

[1]	YANG Kaifei, ZHU Jingge, ZHANG Yangyang, ZHAO Junguo, GAO Yuyue, HU Huanhuan, JI Guojie. Effect of sorafenib induced apoptosis and autophagy on drug resistance in HeLa cells [J]. Basic & Clinical Medicine, 2024, 44(4): 467-473.
[2]	LI Na, LI Tao, YANG Dongli, YAO Yuan. Honokiol inhibits the proliferation of human adipose-derived mesenchymal stem cells [J]. Basic & Clinical Medicine, 2024, 44(4): 483-488.
[3]	ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin. Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib [J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
[4]	AN Qi, QI Guangzhao, HAN Chao. Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(3): 333-338.
[5]	OUYANG Yunlang, ZHANG Ning, CHEN Liping, JIA Bingshen, JIAO Tuo. Tetrandrine attenuates IL-1β-induced injury of human articular chondrocytes in vitro [J]. Basic & Clinical Medicine, 2024, 44(2): 174-179.
[6]	QIN Xiaoying, LIU Hui, HAN Chongfang, HE Jiandong. Improving circadian rhythm disturbance reduces myocardial ischemia-reperfusion injury in diabetic rats [J]. Basic & Clinical Medicine, 2024, 44(2): 231-234.
[7]	LU Huiying, WANG Jianguo. Downregulation of demethylase FTO inhibits proliferation of human liver cancer cell line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(2): 185-191.
[8]	SU Shixiang, WANG Yuyang, QIN Zongshuai, HUANG Guixiang, XU Jian, CEN Lanying, QIN Yueqiu. miR-142-3p inhibits cerulein-induced apoptosis of rat pancreatic exocrine cell line AR42J by regulating Hmgb1 [J]. Basic & Clinical Medicine, 2024, 44(1): 23-30.
[9]	CHEN Ning, PENG Tianying, ZHANG Weimiao, GAO Yanuo, LI Xuan, YAN Caizhen, LI Junxia. Synergistic pro-apoptotic effect of triptolide combined with doxorubicin in human breast cancer cell line MCF-7 [J]. Basic & Clinical Medicine, 2023, 43(8): 1186-1192.
[10]	MIAO Miao, LIU Yan, ZHANG Huan, ZHAO Huichao, LI Zhuofan, ZHANG Haolan, YUAN Panpan. Expression of death receptor apoptosis pathway- correlated factors in pancreatic tissue of mouse diabetic model [J]. Basic & Clinical Medicine, 2023, 43(8): 1254-1258.
[11]	ZHANG Peibo, LI Yi. Total flavonoids of Hippophae rhamnoides L. inhibits proliferation of bladder cancer cell line T24 [J]. Basic & Clinical Medicine, 2023, 43(7): 1122-1126.
[12]	YANG Weizhu, LIU Zhong, ZHANG Fenglin, HUANG Yanlin, SUN Jin, TIAN Xinhua. NOX4-mediated oxidative stress is involved in the occurrence of pituitary adenoma hemorrhagic stroke [J]. Basic & Clinical Medicine, 2023, 43(7): 1040-1044.
[13]	XIANG Caixia, HUANG Bintao, HAO Jian. Research progress of anti-apoptotic inhibitor venetoclax in treatment of myeloid leukemia [J]. Basic & Clinical Medicine, 2023, 43(5): 833-836.
[14]	ZHANG Mengyao, NIU Shu, CAI Jing, ZHAO Zhigang, ZHOU Yan. Effect of miR-140-5p targeting HMGB1/IκB-α axis on retinopathy of diabetic rats [J]. Basic & Clinical Medicine, 2023, 43(4): 615-620.
[15]	LIU Yue, CAO Yang, GU Weiying, SHANG Limei, LIU Yan. Decitabine combined with arsenic trioxide inhibits proliferation and promotes apoptosis of acute myeloid leukemia cell lines [J]. Basic & Clinical Medicine, 2023, 43(4): 608-614.